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Introdução: As complicações cardiovasculares pós-operatórias estão associadas a 
internamentos mais longos, maiores custos, assim como taxas mais elevadas de complicações e 
mortalidade. 
Objetivos: Avaliar determinantes de eventos cardíacos major no período pós-operatório de 
cirurgia não cardíaca. 
Métodos: Foram elegíveis 4398 doentes admitidos numa Unidade de Cuidados Intensivos 
Cirúrgica entre 1 de janeiro de 2006 e 19 de julho de 2013. Os eventos cardíacos major foram 
registados. Os scores APACHE II e SAPS II foram calculados e as variáveis envolvidas analisadas 
individualmente . O risco cardíaco foi determinado pelo Revised Cardiac Risk Index. Tempo de 
internamento e mortalidade na unidade pós-operatória foram igualmente registados. Após 
análise descritiva, testes de Mann-Whitney, Chi-quadrado e exato de Fisher foram usados para 
comparação entre grupos. Foi realizada análise multivariada com regressão logística  para avaliar 
determinantes independentes. 
Resultados: 107 doentes (2.43%) registaram eventos cardíacos major. FiO2 (OR 38.97, 95% CI 
10.81 – 140.36), história de doença isquémica cardíaca (OR 3.38, 95% CI 2.12 – 5.39), história de 
insuficiência cardíaca congestiva (OR 2.39, 95% CI 1.49 – 3.85), diabetes tratada com insulina 
(OR 2.93, 95% CI 1.66 – 5.19), SAPS II (OR 1.03, 95% CI 1.01 – 1.05) e tempo de internamento na 
unidade de cuidados intensivos cirúrgica (OR 1.01, 95% CI 1.00 – 1.01) foram indentificados 
como preditores independentes. 
Conclusões: FiO2, história de doença isquémica cardíaca, história de insuficiência cardíaca 
congestiva, diabetes tratada com insulina, SAPS II e tempo na unidade de cuidados intensivos 
cirúrgica revelaram-se preditores independentes de eventos cardíacos major.  
Palavras-chave:  





















Introduction: Postoperative cardiovascular complications are associated with longer hospital 
length of stay, higher costs along with increased morbidity and mortality. 
Objectives: The aim was to evaluate possible predictors involved in the setting of major cardiac 
events after non-cardiac surgery. 
Methods: 4398 patients admitted at the Surgical Intensive Care Unit between 1st January 2006 
and 19th July 2013. Major cardiac events were recorded. APACHE II and SAPS II were calculated 
and all variables entered as parameters were evaluated independently. Cardiac risk was 
evaluated according to Revised Cardiac Risk Index variables. Time and mortality in post-
anesthesia unit was also registered. Descriptive analysis were presented and Mann-Whitney 
test, Chi-Square or Fischer’s exact test were used for univariate analysis. Multivariate analysis 
with logistic regression was performed to assess independent factors. 
Results: 107 people (2.43%) developed major cardiac events. FiO2 (OR 38.97, 95% CI 10.81 – 
140.36), history of ischemic heart disease (OR 3.38, 95% CI 2.12 – 5.39), history of congestive 
heart disease (OR 2.39, 95% CI 1.49 – 3.85), insulin therapy for diabetes mellitus (OR 2.93, 95% 
CI 1.66 – 5.19), SAPS II (OR 1.03, 95% CI 1.01 – 1.05) and length of stay in the surgical intensive 
care unit (OR 1.01, 95% CI 1.00 – 1.01) were considered independent predictors for 
postoperative major cardiac events. 
Conclusions: FiO2, history of ischemic heart disease or congestive heart disease, insulin therapy 




































AMI Acute myocardial infarction 
APACHE II Acute Physiology and Chronic Health Evaluation 
ASA  American Society of Anesthesiology Physical Status 
CI  Confidence interval 
MCE Major cardiac event 
MET Metabolic equivalents 
NSQIP National Surgical Quality Improvement Program 
OR Odds Ratio 
PACU Post-Anesthesia Care Unit 
P25-75 Percentiles 25 to 75 
RCRI Revised Cardiac Risk Index 
SAPS II Simplified Acute Physiology Score 
SICU Surgical Intensive Care Unit 
Introduction 
 
Surgical care is nowadays a determinant part of health care all around the world, with an 
estimated amount of 234 million procedures every year, equivalent to roughly 4% of the global 
population per year (1).  Although the benefits of the procedure most of the times outweigh the 
potential dangers, there is still considerable perioperative risk of complications and mortality, 
depending on patient’s comorbidities, quality of healthcare or type of surgery performed.  
Changes in demographics, with the ageing of the population, threaten to increase this problem 
in the near future. Elderly requires surgery approximately four times as often as the rest of the 
people (2) and even though age per se is only associated with a small increase in the complication 
rate and mortality, the frequency of surgical procedures raises with the patients age and 
comorbidities are more common, thus raising perioperative risk (3). Objective information 
regarding postoperative complication rate is still sparse in underdeveloped regions, but recent 
data from industrialized countries suggested a complication rate of 7-11% (4).  
During perioperative period, ischemia has long been known to occur more often postoperatively 
(5), now recognized as a result of an individual stress response dependent on patient risk factors, 
type of surgery and circumstances of the procedure. Increased myocardial oxygen demand (e.g. 
tachycardia and hypertension) or decreased blood supply (e.g. hypotension, anemia) are known 
to predispose to ischemic injury and may result in acute myocardial infarction or other major 
cardiac events (MCE), such as congestive heart failure, arrhythmias or even cardiac arrest (6).  
MCE are relatively uncommon, but their occurrence imply longer hospital stay, higher treatment 
costs and they are associated with mortality and morbidity (7). The frequency of these episodes 
varies considerably depending on the characteristics of the studied population, but an incidence 
of 2-4% might be an accurate estimate (8-10). These events might be difficult to predict, as they 
frequently cause no early symptoms (11) or changes in electrocardiography.  
An accurate preoperative assessment is therefore essential to guide an individualized patient 
approach and establish prophylactic treatment, optimize perioperative management and early 
detection of possible cardiac complications.  
Scoring systems were developed and are now in use as an additional tool to guide and optimize 
patient’s approach in the postoperative setting, such as APACHE II (Acute Physiology and Chronic 
Health Evaluation) and SAPS II (Simplified Acute Physiology Score). Both these severity-of-
disease classification system designed to evaluate the morbidity in adult patients admitted to 
intensive care units. In APACHE II(12), a quantitative score (range 0 to 71) is attributed according 
to age, previous state of health and 12 physiologic measures (arterial pO2, body temperature, 
mean arterial pressure, arterial pH, heart rate, respiratory rate, serum sodium, serum 
potassium, serum creatinine, hematocrit, white blood cell count and Glasgow Coma Scale. On 
the other hand, SAPS II(13) is calculated according to the values of 17 variables: age, heart rate, 
systolic blood pressure, body temperature, type of admission, Glasgow Coma Scale, mechanical 
ventilation, arterial pO2, FiO2, serum urea, serum sodium, serum potassium, serum bicarbonate, 
serum bilirubin, urine output, white blood cell count and history of chronic disease. 
Few studies have focused on the cardiac risk on an unselected sample. Therefore, the aim of this 
study is to identify the incidence of major cardiac events and its possible predictors on a broad 
surgical population undergoing non-cardiac surgery.  
 
Methods 
The study design consists on a retrospective cohort performed at the Post-Anesthesia Care Unit 
(PACU) in the postoperative period. Within the PACU, there is a Surgical Intensive Care Unit 
(SICU) with five beds, where critically ill patients are admitted, closely monitored and treated. 
All patients who underwent elective or emergent non-cardiac surgery between 1st January 2006 
and 19th July 2013 were eligible for inclusion. Patients less than 18 years old, medical patients, 
re-admittance for the same medical reason during the studied period and hospitalization time 
lower than 12 hours were excluded. The full study protocol was approved by the research ethics 
committee of the hospital. 
We considered MCE as the occurrence of at least one of the following complications: acute 
myocardial infarction, pulmonary edema, ventricular fibrillation, primary cardiac arrest and 
complete heart block. Acute myocardial infarction was defined following the European Society 
of Cardiology/American College of Cardiology criteria(14). 
The following variables were registered on the admission at SICU: age, gender and type of 
surgery (elective or emergent).  We evaluated an individual cardiac risk profile according to the 
Revised Cardiac Risk Index (RCRI) developed by Lee et al(8):  high-risk type of surgery, history of 
congestive heart failure, history of ischemic heart disease, history of cerebrovascular disease, 
insulin therapy for diabetes mellitus and preoperative serum creatinine >2.0 mg/dL. 
APACHE II and SAPS II were both calculated according to original author’s description using 
hemodynamic factors, complete blood count and blood biochemistry measured during the first 
24 hours. Variables included mean arterial pressure, systolic pressure, body temperature, heart 
and respiratory rate, hematocrit, leucocyte count, serum sodium, serum potassium, arterial pH, 
arterial pO2, arterial pCO2, serum bicarbonate, serum total bilirubin, serum urea, serum 
creatinine, as well as Glasgow Coma Scale.  
Failure of at least one organ defined in APACHE II was registered as organ insufficiency. 
Creatinine higher than 2mg/dL associated with urinary debit lower than 500mL/d was assigned 
as postoperative renal insufficiency. Use of artificial ventilation was also recorded, as well as the 
time and mortality in SICU.  
Descriptive analysis of variables was used to summarize data. Kolmogorov-Smirnov Test was 
performed to assess data distribution. A univariate analysis was done to compare each variable 
in the patients with or without MCE. Chi-Square or Fischer’s Exact Test were used to compare 
categorical variables and Mann-Whitney U Test to compare continuous variables between the 
two groups of subjects. To adjust the increased likelihood of type I error in multiple comparisons, 
Bonferroni correction was applied to control the significance level. Variables were considered 
significant if p≤0.001. 
To assess independent predictor factors of MCE, a multivariate analysis using a multiple binary 
logistic regression with forward conditional elimination was performed, using covariates with 
p≤0,001 in the univariate analysis calculating Odds Ratio (OR) with Confidence Intervals (CI) of 
95%. 
Version 22.0 of SPSS for Windows (SPSS, Chicago, IL) was used for data analysis and storage. 
Descriptive data was presented as median and percentile interval (P25-75) for the continuous 
variables after confirming the variables did not follow a normal distribution.  
 
Results 
During the study period, 4561 patients who underwent non-cardiac procedures were admitted 
to the SICU. 53 had a SICU stay lower than 12 hours, 42 were admitted more than once to the 
SICU for the same reason, 38 were younger than 18 years old and 30 were medical patients, 
resulting in 163 excluded and 4398 eligible patients. 107 patients (2.43%) developed at least one 
MCE during the SICU stay.  
107 patients (2.43%) developed MCE during their stay. We detected 59 acute myocardial 
infarctions, 34 cases of acute pulmonary edema, 19 primary cardiac arrests, 8 ventricular 
fibrillation or other ventricular arrhythmias and 4 complete heart blocks, thus totalizing 124 
MCE.  
A comparison between the individuals who did and those who didn’t developed major cardiac 
complications is presented on Table 1. Patients who developed MCE presented more frequently 
with history of ischemic heart disease (13.2% vs 46.7%, p<0.001), congestive heart disease 
(14.8% vs 51.4%, p<0.001), diabetes with insulin therapy (4.5% vs 19.6%, p<0.001), 
postoperative renal insufficiency (6.0% vs 24.3%, p<0.001) and RCRI higher than 2 (1.8% vs 
10.1%, p<0.001). Patients who developed MCE during SICU stay had higher serum creatinine, 
serum total bilirubin and FiO2, as well as lower systolic pressure, mean arterial pressure, 
hematocrit and arterial pH. Mechanical ventilation (29.7% vs 61.7%, p<0.001) was more 
frequent in patients that developed MCE during SICU stay. 
Severity of disease scores, length of stay and mortality in SICU are summarized on Table 2. 
Patients who developed MCE had higher SAPS II (median 18 vs 27, p<0.001) and APACHE II 
(median 8 vs 13, p<0.001), as well as longer stay (median 20 vs 48, p<0.001) and mortality (1.0% 
vs 15.9%, p<0.001).  
Multiple logistic regression was used to assess the covariate effects of each variable in the 
setting of MCE. The resulting values are described on Table 3. Independent predictors of MCE 
were identified as FiO2  (OR 38.97, 95% CI 10.81 – 140.36), history of ischemic heart disease (OR 
3.38, 95% CI 2.12 – 5.39), history of congestive heart disease (OR 2.39, 95% CI 1.49 – 3.85), 
insulin therapy for diabetes mellitus (OR 2.93, 95% CI 1.66 – 5.19), SAPS II (OR 1.03, 95% CI 1.01 
– 1.05) and length of stay in SICU (OR 1.01, 95% CI 1.00 – 1.01).  
 
Discussion 
In the present study, we assessed the incidence and possible predictors involved in the setting 
of MCE following non-cardiac surgery.  
The 2.43% rate of MCE during the postoperative period was similar to other reference studies 
in the past (8-10).  
Similarly, myocardial ischemia remains as the primary postoperative cardiac events with 59 
acute myocardial infarctions (AMI), accounting for approximately 48% of the total MCE. Previous 
research reported an incidence of AMI between 1.4 and 38% (15). AMI also tends to occur more 
frequently within the first three days after surgery. Devereaux et al (16) has shown that 74.1% of 
the AMI occurred in the first 48 hours.  
The exact mechanisms of perioperative myocardial ischemia remain yet to be fully understood 
but the setting on the postoperative period is potentially concerning since most AMI occur 
without chest pain. Mangano et al (11)  reported these episodes of myocardial ischemia to be 
asymptomatic up to 90% of the times, but recent studies show that it might actually be lower, 
as symptoms were noticed in 34.7% (16) and 40.7% (17). It is hypothesized that this is related to 
the higher incidence early after surgery (18) and, therefore, a period of altered nociception and 
blunting of such hallmarks. However, even in the presence of pain or discomfort, these 
symptoms are frequently attributed to the surgical aggression and a normal variation in the 
postoperative context, turning out to be a potentially misleading check point to the clinician. 
Even in the presence of suspicion, things can turn out even more challenging. 
Electrocardiographic changes can be transient and associated with hemodynamic changes after 
surgery and therefore go unnoticed, since there is frequently no ST-elevation in the setting of 
AMI(16, 17). Furthermore, these patients usually don’t communicate due to invasive ventilation. 
AMI are then detected late, explaining its high incidence, morbidity and mortality. 
Concerning these difficulties, some authors suggest that in the perioperative period physicians 
should adopt the clinical entity known as myocardial injury after non-cardiac surgery instead of 
use the non-surgical diagnostic criteria and, therefore, introduce troponin surveillance as the 
gold standard for detection of myocardial ischemia, regardless of the symptoms(19) . It is still 
needed to take into account though that several other situations might cause isolated troponin 
increase(20). 
History of ischemic heart disease, congestive heart disease or preoperative insulin therapy have 
all been identified as independent factors for MCE (8). A significant relation with the other three 
remaining variables established by Lee et al (8) for his RCRI could not be found in our analysis. 
Also, the rate of MCE was lower than what we verified, raising the hypothesis that differences 
in both sample and study design may have a significant role: whereas our study aimed to 
evaluate determinants in a broad undifferentiated population, Lee et al (8) evaluated the 
predictors involved in a size-equivalent sample but including patients aged 50 or older 
undergoing non-cardiac surgery that requires hospital admission. Consequently, the 1.4% 
incidence of MCE (8) is most likely an underestimation of the current incidence, as elderly people 
undergoing surgery continues to increase. These findings help to sustain RCRI as an easy tool to 
apply in patient care, but with limited applicability: although it discriminates moderately well 
low versus high risk patient groups, its efficacy to accurately predict MCE after vascular non-
cardiac surgery might be hampered (21) .  
Newer studies have been developed to better assess the RCRI validity in the present. Davis et al 
(22) described recently that a five variable model consisting on high-risk type of surgery, history 
of ischemic heart disease, congestive heart failure, cerebrovascular disease, and a preoperative 
GFR < 30 mL/min might result in a superior prediction accuracy for MCE after elective non-
cardiac surgery. Further investigation is needed in order to clarify optimal guidelines to assess 
and treat patients in this “gray area”.  
FiO2 may be a good reflection of the underlying state of the patients and, therefore, it is not 
surprising to see them as independent factors for major cardiac complications: higher FiO2 is 
frequently required in patients with impaired tissue perfusion or adequate oxygenation. It is 
reasonable to admit that in the presence of other factors influencing oxygen tissue delivery, such 
as hypovolemia or anemia, functional reserve and compensatory mechanisms may be severely 
diminished, thus making the oxygen supplementation insufficient on its own (23). Regarding SAPS 
II, it remains as one of the many prognostic and severity scoring systems currently in use in many 
intensive care units. In our particular context, SAPS II has shown in the past a slightly better 
performance than APACHE II (24).  
Occurrence of MCE has also been independently correlated with longer stays, which comes 
accordingly to the previous reports (25, 26). Fleischmann et al(26) reported a mean increase of 11 
days in the hospital stay following perioperative cardiac complications. Such can be explained 
by a more urgent need to monitor closely these patients, due to hemodynamic instability 
following the cardiac complications, presence of concomitant chronic disease or both, until they 
are able to be safely transferred.  
Despite recent associations correlating the presence of anemia and adverse morbidity and 
mortality after non-cardiac surgery (27, 28), our study could not find a significant difference and 
therefore an independent correlation between postoperative hematocrit values and MCE.  
We identify as strong points of our study the valid population representation, with a significant 
number of individuals in a surgical intensive care unit in our country, as well as an extensive 
patient-related variables registration, which allowed a detailed characterization of our sample. 
Besides the limitations inherent to a retrospective cohort study, others are present on our study 
design. Preoperative risk assessment is roughly based on three broad but connected categories 
including several risk factors: surgery-related, patient-related or dependent on patient’s 
functional status. Although we took into account both type of admission and high-risk surgery, 
as well as patient-related factors, our data did not include any measure of the functional status 
of each individual, commonly extrapolated by their ability to perform different tasks on their 
daily life and expressed as metabolic equivalents (MET). Even though potentially controversial, 
since limited exercise tolerance has already been correlated in the past with higher risk for 
postoperative complications(29), further investigation suggested there is no substantial 
association between preoperative functional capacity and MCE or death in the postoperative 
period(30). Nevertheless, we include this is a limitation as we do not possess any data on this 
respect. 
The lack of an ASA physical status for our sample population was also problematic. A recent risk 
prediction model for intraoperative and postoperative myocardial infarction or cardiac arrest 
was developed using the American College of Surgeons National Surgical Quality Improvement 
Program (NSQIP) and including the ASA physical status classification as one of its five predictors. 
Although this model has already been reported as having performed better than RCRI, the Lee 
risk index remains as a reliable cardiac-risk index in non-cardiac surgery. Furthermore, the 
inexistence of other possible cardiac complications of interest preconized as outcomes on NSQIP 
model, such as pulmonary edema and complete heart block, raises the belief that these two 
indexes should be different perspectives of the same background and, therefore, interpreted 
complementarily regarding patient’s prognosis. 
 
Conclusions 
The incidence of MCE after non-cardiac surgery was 2.43%, similar to previous reports. AMI 
remains as the most common cardiac complication with 48% of the total MCE.  
FiO2, history of ischemic heart disease or congestive heart disease, insulin therapy for diabetes 
mellitus, SAPS II and length of stay in SICU were found as independent variables in the setting of 
MCE. 
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Table 1 – Univariate analysis of predictors of major cardiac events 
 
MCE – Major cardiac event; P25-75 – percentiles 25 to 75; RCRI – Revised Cardiac Risk Index 
a – Mann-Whitney U test        b – Chi-Square or Fischer Test  
Variables No MCE MCE p value 
 
Age, median (P25-75) 65 (53-74) 70 (58-77) 0.002 a 
Gender, n (%)   0.964 b 
    Male 2616 (61) 65 (60.7)  
    Female 1675 (39) 42 (39.3)  
Type of admission, n (%)   0.003 b 
    Elective surgery 3744 (87.3) 83 (77.6)  
    Non-elective surgery 547 (12.7) 24 (22.4)  
High-risk surgery, n (%) 2322 (54.1) 60 (56.1) 0.688 b 
History of ischemic heart disease, n (%) 567 (13.2) 50 (46.7) <0.001 b 
History of congestive heart disease, n (%) 636 (14.8) 55 (51.4) <0.001 b 
History of cerebrovascular disease, n (%) 543 (12.7) 16 (15.0) 0.481 b 
Preoperative insulin therapy, n (%) 194 (4.5) 21 (19.6) <0.001 b 
Chronic renal failure, n (%) 272 (6.3) 9 (8.4) 0.387 b 
Postoperative renal insufficiency, n (%) 259 (6.0) 26(24.3) <0.001 b 
Organ insufficiency, n (%) 656 (15.3) 26 (24.3) 0.011 b 
RCRI, n (%)   <0.001 b 
    ≤2 3996 (98.2) 295 (89.9)  
    >2 74 (1.8) 33 (10.1)  
Glasgow coma scale, n (%)   0.010 b 
    ≤9 49 (1.1) 5 (4.7)  
    >9 4242 (98.9) 102 (95.3)  
Body temperature, median (P25-75) 35.8 (34.6-36.0) 35.3 (33.9-36.0) 0.006 a 
Heart rate, median (P25-75) 83 (69-98) 87 (67-113) 0.116 a 
Respiratory rate, median (P25-75) 14 (12-16) 14 (14-16) 0.018 a 
Systolic pressure, median (P25-75) 122 (102-144) 105 (84-135) <0.001 a 
Mean arterial pressure, median (P25-75) 85 (71-96) 71 (59-87) <0.001 a 
Hematocrit, median (P25-75) 33 (29.9-36.3) 31 (27-35.8) <0.001 a 
Urea, median (P25-75) 30 (20-40) 34 (20-59) 0.001 a 
Serum creatinine, median (P25-75) 8.2 (6.5-11) 10.1 (7.8-17.1) <0.001 a 
Serum total bilirubin, median (P25-75) 4 (1-7) 5 (4-10) <0.001 a 
Leucocytes, median (P25-75) 11 (8-14) 11,5 (8-15,3) 0.513 a 
Serum sodium, median (P25-75) 140 (137-142) 141 (129-164) 0.001 a 
Serum potassium, median (P25-75) 3.8 (3.5-4.1) 3.7 (3.3 – 4.3) 0.762 a 
Ventilated, n (%) 1275 (29.7) 66 (61.7) <0.001 b 
FiO2, median (P25-75) 40 (35-40) 40 (40-60) <0.001 a 
Arterial pH, median (P25-75) 7.40 (7.35-7.40) 7.36 (7.30-7.40) <0.001 a 
Arterial pO2, median (P25-75) 100 (100-110) 100 (89-123) 0.500 a 
Arterial pCO2, median (P25-75) 39.4 (35-45) 41.2 (35.3-45.3) 0.037 a 
Serum bicarbonate, median (P25-75) 22 (21-24) 22 (19.6-25.2) 0.315 a 
Table 2 – Severity of disease scores, length of stay and mortality. 
 
 
APACHE II- Acute Physiology and Chronic Health Evaluation; MCE – Major cardiac event; SAPS II - 















 No MCE MCE p value 
    
SAPS II, median (P25-75) 18 (13,33 – 26,00) 27 (20 –  42) <0.001 
APACHE II, median (P25-75) 8 (6 – 12) 13 (9 – 20) <0.001 
Time in SICU - hours, median (P25-75) 20 (16 – 41) 48 (22 – 104) <0.001 
Mortality in SICU, n (%) 43 (1) 17 (15.9) <0.001 
Table 3 – Multivariate regression analysis for independent predictors of major cardiac events 
 
APACHE II- Acute Physiology and Chronic Health Evaluation; CI – Confidence Interval; OR – Odds Ratio; 








Simple OR p value 
 
Adjusted OR (CI 95%) 
 
p value a 
History of ischemic heart disease 5.76 (3.90 –  8.51) <0.001 3.38 (2.12 –  5.39) <0.001 
History of congestive heart disease 6.08 (4.12 –  8.96) <0.001 2.39 (1.49 –  3.85) <0.001 
Preoperative insulin therapy 5.16 (3.13 –  8.49) <0.001 2.93 (1.66 –  5.19) <0.001 
Postoperative renal insufficiency 1.36 (0.68 –  2.72) 0.388 - - 
RCRI 6.04 (3.94 –  9.26) <0.001 - - 
Systolic pressure 0.98 (0.98 – 0.99) <0.001 - - 
Mean arterial pressure 0.97 (0.96 – 0.98) <0.001 - - 
Hematocrit 0.93 (0.90 – 0.96) <0.001 - - 
Urea 1.01 (1.10 – 1.02) <0.001 - - 
Creatinine 1.02 (1.01 – 1.04) <0.001 - - 
Total bilirubin 1.00 (1.00 – 1.01) 0.418 - - 
Ventilated 3.81 (2.57 – 5.65) <0.001 - - 
FiO2 203.26 (77.31 – 534.5) <0.001 38.97 (10.81 – 140.36) <0.001 
SAPS II 1.06 (1.04 – 1.08) <0.001 1,03 (1.01 – 1.05) <0.001 
APACHE II 1.16 (1.13 – 1.19) <0.001 - - 
Time in SICU (hours) 1.01 (1.01 – 1.01) <0.001 1.01 (1.00 – 1.01) <0.001 
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